AbbVie Wants Hypertension Drug Antitrust Row Sent To NJ

By Jeannie O'Sullivan ( November 2, 2020, 8:29 PM EST) -- AbbVie Inc. and other pharmaceutical companies told a New York federal court Friday that lawsuits alleging they paid off competitors to delay generic competition for blood pressure drug Bystolic should be moved to New Jersey, the nation's "pharmaceutical epicenter," where most of the defendants and witnesses are based....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!